Cargando…

Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk

Despite numerous studies on major depressive disorder (MDD) susceptibility, the precise underlying molecular mechanism has not been elucidated which restricts the development of etiology-based disease-modifying drug. Major depressive disorder treatment is still symptomatic and is the leading cause o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srivastava, Ankit, Singh, Priyanka, Gupta, Hitesh, Kaur, Harpreet, Kanojia, Neha, Guin, Debleena, Sood, Mamta, Chadda, Rakesh Kumar, Yadav, Jyoti, Vohora, Divya, Saso, Luciano, Kukreti, Ritushree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514561/ https://www.ncbi.nlm.nih.gov/pubmed/31018568 http://dx.doi.org/10.3390/ijms20081993

Ejemplares similares

Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers
por: Singh, Priyanka, et al.
Publicado: (2023)

Association of serotonin transporter (SLC6A4) & receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study
por: Basu, Aniruddha, et al.
Publicado: (2015)

Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations
por: Jajodia, Ajay, et al.
Publicado: (2015)

Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility
por: Guin, Debleena, et al.
Publicado: (2022)

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017)

Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment
por: Thakran, Sarita, et al.
Publicado: (2020)

Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
por: Guin, Debleena, et al.
Publicado: (2019)

Corrigendum: Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
por: Guin, Debleena, et al.
Publicado: (2020)

In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017)

Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms
por: Wadhwa, Ravisha, et al.
Publicado: (2017)

A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson’s disease
por: Guin, Debleena, et al.
Publicado: (2017)

Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer’s Disease
por: Talwar, Puneet, et al.
Publicado: (2021)

Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
por: Singh, Anju, et al.
Publicado: (2019)

Oxidative Stress: Role and Response of Short Guanine Tracts at Genomic Locations
por: Singh, Anju, et al.
Publicado: (2019)

Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes
por: Singh, Anju, et al.
Publicado: (2022)

Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
por: Talwar, Puneet, et al.
Publicado: (2019)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy
por: Rawat, Chitra, et al.
Publicado: (2020)

Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile
por: Mishra, Manish Kumar, et al.
Publicado: (2021)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Women psychiatrists in India: A reflection of their contributions
por: Sood, Mamta, et al.
Publicado: (2010)

Indian research on women and psychiatry
por: Chadda, Rakesh K., et al.
Publicado: (2010)

Women in psychiatry: A view from the Indian subcontinent
por: Sood, Mamta, et al.
Publicado: (2009)

General hospital psychiatry in India: History, scope, and future
por: Chadda, Rakesh Kumar, et al.
Publicado: (2018)

Psychosocial rehabilitation for severe mental illnesses in general hospital psychiatric settings in South Asia
por: Sood, Mamta, et al.
Publicado: (2015)

Does serotonin reuptake inhibitor therapy increase the risk of post-sphincterotomy bleeding in patients undergoing endoscopic retrograde cholangio-pancreatography?
por: Yadav, Divya, et al.
Publicado: (2017)

Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies
por: Verma, Sagar, et al.
Publicado: (2021)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Experiences of a sensitization program on common mental disorders for primary care physicians using problem-based learning approach
por: Chadda, Rakesh K., et al.
Publicado: (2009)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pdapc1o9g0avlc3bnse3br5udg